According to the World Health Organization (WHO), in 2015 and 2016 alone, malaria killed 446,000 and 445,000, respectively, in Africa. Adding the manufacturing of antimalarials in its products line is essential, if Tangent is truly to become a partner in the communities of which it is part. Therefore, Tangent will add the production of chloroquine to our offerings, in the second phase of the pharmaceutical plant.